FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
E-3040, 145096-30-6, E-3040 Intermediate 14538-50-2, stock 677.2g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
E-3040, 145096-30-6, E-3040 Intermediate 500-22-1, stock 540.3g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
E-3040, 145096-30-6, E-3040 Intermediate 145096-35-1, stock 660.1g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
E-3040, 145096-30-6, E-3040 Intermediate 145096-36-2, stock 251.6g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
E-3040, 145096-30-6, E-3040 Intermediate 145096-37-3, stock 691.1g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
E-3040, 145096-30-6, E-3040 Intermediate 598-52-7, stock 596.2g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
E-3040, 145096-30-6, E-3040 Intermediate 145096-30-6, stock 383.1g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |